Evidence map›Paper›PMID 39602262›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Lethal COVID-19 associates with RAAS-induced inflammation for multiple organ damage including mediastinal lymph nodes.

Michael J Topper, Joseph W Guarnieri, Jeffrey A Haltom, Amy Chadburn, Henry Cope, Justin Frere, Julia An, Alain Borczuk, Saloni Sinha, JangKeun Kim and 50 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Mitochondrial antioxidants abate SARS-COV-2 pathology in mice.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

60 authors.

Michael J Topper *COVID-19 International Research Team, Medford, MA 02155.
Joseph W Guarnieri *COVID-19 International Research Team, Medford, MA 02155.
Jeffrey A HaltomCOVID-19 International Research Team, Medford, MA 02155.
Amy ChadburnPathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065.ORCID 0000-0002-9499-8638
Henry CopeSchool of Medicine, University of Nottingham, Derby DE22 3DT, United Kingdom.
Justin FrereIcahn School of Medicine, Mount Sinai, New York, NY 10023.
Julia AnCOVID-19 International Research Team, Medford, MA 02155.
Alain BorczukWeill Cornell Medicine, New York, NY 10065.
Saloni SinhaWeill Cornell Medicine, New York, NY 10065.
JangKeun KimWeill Cornell Medicine, New York, NY 10065.
Jiwoon ParkWeill Cornell Medicine, New York, NY 10065.
Daniel ButlerWeill Cornell Medicine, New York, NY 10065.
Cem MeydanWeill Cornell Medicine, New York, NY 10065.
Jonathan FooxWeill Cornell Medicine, New York, NY 10065.
Yaron BramWeill Cornell Medicine, New York, NY 10065.
Stephanie A RichardInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD 20814.
Nusrat J EpsiInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD 20814.
Brian AganInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD 20814.ORCID 0000-0002-5114-1669
Josh G ChenowethHenry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD 20817.
Mark P SimonsInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD 20814.
David TribbleInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD 20814.
Timothy BurgessInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD 20814.
Clifton DalgardDepartment of Anatomy, Physiology & Genetics, Uniformed Services University, Bethesda, MD 20814.
Mark T HeiseUniversity of North Carolina, Chapel Hill, NC 27599.ORCID 0000-0001-5829-8477
Nathaniel J MoormanUniversity of North Carolina, Chapel Hill, NC 27599.ORCID 0000-0003-4952-6858
Victoria K BaxterUniversity of North Carolina, Chapel Hill, NC 27599.ORCID 0000-0003-0916-360X
Emily A MaddenUniversity of North Carolina, Chapel Hill, NC 27599.
Sharon A Taft-BenzUniversity of North Carolina, Chapel Hill, NC 27599.
Elizabeth J AndersonUniversity of North Carolina, Chapel Hill, NC 27599.ORCID 0000-0001-7877-1639
Wes A SandersUniversity of North Carolina, Chapel Hill, NC 27599.
Rebekah J DickmanderUniversity of North Carolina, Chapel Hill, NC 27599.
Katherine BeigelCOVID-19 International Research Team, Medford, MA 02155.
Gabrielle A WidjajaCOVID-19 International Research Team, Medford, MA 02155.
Kevin A JanssenCOVID-19 International Research Team, Medford, MA 02155.
Timothy LieCOVID-19 International Research Team, Medford, MA 02155.
Deborah G MurdockCOVID-19 International Research Team, Medford, MA 02155.
Alessia AngelinCOVID-19 International Research Team, Medford, MA 02155.
Yentli E Soto AlbrechtCOVID-19 International Research Team, Medford, MA 02155.
Arnold Z OlaliCOVID-19 International Research Team, Medford, MA 02155.
Zimu CenCOVID-19 International Research Team, Medford, MA 02155.
Joseph DybasCOVID-19 International Research Team, Medford, MA 02155.
Waldemar PriebeCOVID-19 International Research Team, Medford, MA 02155.
Mark R EmmettCOVID-19 International Research Team, Medford, MA 02155.ORCID 0000-0002-9248-5767
Sonja M BestCOVID-19 International Research Team, Medford, MA 02155.ORCID 0000-0003-0206-297X
Maya Kelsey JohnsonCOVID-19 International Research Team, Medford, MA 02155.
Nidia S TrovaoCOVID-19 International Research Team, Medford, MA 02155.ORCID 0000-0002-2106-1166
Kevin B ClarkCOVID-19 International Research Team, Medford, MA 02155.ORCID 0000-0003-0544-2150
Victoria ZaksasCOVID-19 International Research Team, Medford, MA 02155.
Robert MellerCOVID-19 International Research Team, Medford, MA 02155.
Peter GrabhamCOVID-19 International Research Team, Medford, MA 02155.
Jonathan C SchislerCOVID-19 International Research Team, Medford, MA 02155.
Pedro M Moraes-VieiraCOVID-19 International Research Team, Medford, MA 02155.ORCID 0000-0002-8263-786X
Simon PollettInfectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD 20814.
Christopher E MasonCOVID-19 International Research Team, Medford, MA 02155.ORCID 0000-0002-1850-1642
Eve Syrkin WurteleCOVID-19 International Research Team, Medford, MA 02155.
Deanne TaylorCOVID-19 International Research Team, Medford, MA 02155.
Robert E SchwartzCOVID-19 International Research Team, Medford, MA 02155.
Afshin Beheshti *COVID-19 International Research Team, Medford, MA 02155.ORCID 0000-0003-4643-531X
Douglas C Wallace *COVID-19 International Research Team, Medford, MA 02155.ORCID 0000-0002-7480-8278
Stephen B Baylin *COVID-19 International Research Team, Medford, MA 02155.

Funding

Assessing the Impact of SARS-CoV-2 on Adipose Tissue Function and Glucose HomeostasisR01DK132879 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI James C Lo, Robert E Schwartz · 2023 to 2026
$2.8M
DATA CENTER FOR EPIDEMIOLOGIC INVESTIGATIONS OF HIVN01AI005072 · NIAID · NEW ENGLAND RESEARCH INSTITUTES, INC. · PI MCKINLAY, SONJA M · 1990 to 1994
–
Bill and Melinda Gates Foundation (GF) INV-046722HHS | NIH | NIAID | Division of Intramural Research (DIR, NIAID) not applicableNIAID NIH HHS Y01 AI005072NIDDK NIH HHS R01 DK132879U.S. Department of Defense (DOD) W81XWH-21-1-0128
6 · The paper itself

Abstract

Lethal COVID-19 outcomes are attributed to classic cytokine storm. We revisit this using RNA sequencing of nasopharyngeal and 40 autopsy samples from patients dying of SARS-CoV-2. Subsets of the 100 top-upregulated genes in nasal swabs are upregulated in the heart, lung, kidney, and liver, but not mediastinal lymph nodes. Twenty-two of these are "noncanonical" immune genes, which we link to components of the renin-angiotensin-activation-system that manifest as increased fibrin deposition, leaky vessels, thrombotic tendency, PANoptosis, and mitochondrial dysfunction. Immunohistochemistry of mediastinal lymph nodes reveals altered architecture, excess collagen deposition, and pathogenic fibroblast infiltration. Many of the above findings are paralleled in animal models of SARS-CoV-2 infection and human peripheral blood mononuclear and whole blood samples from individuals with early and later SARS-CoV-2 variants. We then redefine cytokine storm in lethal COVID-19 as driven by upstream immune gene and mitochondrial signaling producing downstream RAAS (renin-angiotensin-aldosterone system) overactivation and organ damage, including compromised mediastinal lymph node function.

Indexed as

COVID-19Lymph NodesRenin-Angiotensin SystemSARS-CoV-2AnimalsCytokine Release SyndromeHumansInflammationMaleMediastinumMiceCOVID-19fibrosisrenin angiotensin aldosterone system

Identifiers

PMID39602262
PMCPMC11626201

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.